Article
Effects of mutations on MUC1-C/ED protein stability and antibody Binding: Structural insight.
Biochemical and biophysical research communications - 15 Aug 2025
Sanyal Dwipanjan, Muzata Danny, Uversky Vladimir N, Kharbanda Surender, Chowdhury Sourav, Jasuja Ravi
Abstract excerpt
Antibody-drug conjugates (ADCs) represent a transformative approach in cancer therapy, combining the specificity of monoclonal antibodies with targeted delivery of potent cytotoxic drugs to tumors. Discovery of novel antigens has been the hallmark for development of ADC therapeutics and MUC1 is one such oncoprotein, which has garnered renewed interest recently. The 3D1 antibody, engineered to bind specifically to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
